Johnson & Johnson Book Value per Share: 22.45
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
JNJ Book Value per Share Rankings
| Overall | 84th percentile | 706 of 4556 |
| Sector | 92nd percentile | 38 of 518 in Healthcare |
| Industry | 92nd percentile | 2 of 26 in Drug Manufacturers - Major |
JNJ Book Value per Share Range, Past 5 Years
| Minimum | 6.77 | Dec 2000 |
| Maximum | 22.71 | Jun 2001 |
| Average | 10.94 |
About Book Value per Share
Book value per share indicates the book value (or accounting value) of each share of stock. Book value is a company's net asset value, which is calculated by total assets minus intangible assets and liabilities. A relatively high book value per share in relation to stock price often occurs when a stock is undervalued.
In the rare circumstance that market price falls below the book value per share, generally a stock is undervalued and might be an attractive buy.
Learn More
You may also be interested in these JNJ related companies
JNJ News
News related to $JNJ, currently-0.6 pct.: 'Stryker says President and CEO MacMillan resigned' http://stks.co/2Ko9
about 3 days ago by TradeBot
about 3 days ago by TradeBot
$JNJ ... swing long started this am is starting to work ... next add area is $65.39ish
about 5 days ago by Leaf_West
about 5 days ago by Leaf_West
$JNJ failed a test of resistance, nice little short opportunity here http://chart.ly/taubwgh
about 6 days ago by optionmaster
about 6 days ago by optionmaster
long $JNJ for dvd looking for break above long long resistance in high 60's. now if they can just avoid a bad news release!
about 6 days ago by Fundies
about 6 days ago by Fundies
$JNJ Insider Sale: $29.6M of stock sold by William Weldon (Director Chairman/ceo) on February 1, 2012 http://stks.co/2F43
about 9 days ago by MarketBrief
about 9 days ago by MarketBrief
@taketheplunge $VRTX That makes little sense to me. More likely a $JNJ BO of $VRTX I would think.
about 9 days ago by SCIGUY
about 9 days ago by SCIGUY
R&D in Quebec pharma industry continues to erode $AZN $JNJ $SNY $MRK
about 11 days ago by michaelbabad
about 11 days ago by michaelbabad
$JNJ Strong Trending 66.315 from 12/27/2011 Hold 5 Days 64% Success http://stks.co/2Bxh 9:33EST #tradeideas #investing #stocks
about 12 days ago by TradeIdeas1
about 12 days ago by TradeIdeas1
Morning News: January 31, 2012 | via @EddyElfenbein http://stks.co/2APO $JNJ $AAPL $RIM
about 13 days ago by STNet
about 13 days ago by STNet
I'd say it was pretty clear that McNeil wasn't anywhere near being on the right track. No-brainer move to change the management again. $JNJ
about 13 days ago by bradloncar
about 13 days ago by bradloncar
Tuesday, January 24, 2012 Stock Market Analysis $MCD $TRV $JNJ $DD $VZ http://stks.co/24EH
about 20 days ago by marketsectors
about 20 days ago by marketsectors
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| JNJ | 64.60 | -0.29 | -0.45% | 176.41B |
| CVS | 43.18 | 0.18 | 0.42% | 56.20B |
| ASTI | 0.83 | 0.02 | 2.85% | 32.31M |
| URRE | 0.95 | -0.08 | -7.73% | 88.89M |
| GNW | 8.73 | -0.17 | -1.96% | 4.29B |
| ATPG | 6.69 | -0.14 | -2.05% | 345.34M |
| VECO | 28.36 | 0.08 | 0.28% | 1.10B |
| AMAT | 12.95 | -0.16 | -1.22% | 17.06B |
| ROCM | 8.08 | 0.12 | 1.51% | 99.06M |
| CYTK | 1.18 | -0.01 | -0.84% | 85.29M |
